Eli Lilly pours $1B into India to turbocharge exports
Eli Lilly is planning to invest roughly $1 billion in India’s pharmaceutical manufacturing capacity, with Hyderabad positioned as a potential export base for the company’s global drug supply. The move signals that Lilly is looking at India not merely as a market for its products but as a production base for global demand, as it…